Пожалуйста, подождите, мы загружаем данные графика
AstraZeneca PLC сообщество
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 14 152,22 ₽, with a 24-hour trading volume of 32,35B ₽. The asset's market cap is 21,94T ₽, after moving -1.33% in the last day.
Tokenized AstraZeneca PLC is trading at 7 268,03 ₽, with a tokenized market cap of 995,61M ₽ and a 24-hour trading volume of 50,56M ₽. The tokenized asset has moved 0.55% in the past 24 hours.